These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32608079)

  • 1. The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene.
    Hoffman EP
    FEBS J; 2020 Sep; 287(18):3879-3887. PubMed ID: 32608079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients.
    Duan D
    Hum Gene Ther; 2018 Jul; 29(7):733-736. PubMed ID: 29463117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology.
    Berger J; Berger S; Hall TE; Lieschke GJ; Currie PD
    Neuromuscul Disord; 2010 Dec; 20(12):826-32. PubMed ID: 20850317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
    Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
    Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
    [TBL] [Abstract][Full Text] [Related